These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15639062)

  • 21. Considerations on pulsoplethysmographic changes in fingers due to iontophoresis with methacholine in subjects with Raynaud's phenomenon.
    Taccola A; Zambelli M
    Minerva Cardioangiol; 2000; 48(4-5):137-46. PubMed ID: 10959150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary Raynaud's phenomenon is associated with microvascular peripheral endothelial dysfunction.
    Taher R; Sara JD; Toya T; Shepherd R; Moder K; Lerman LO; Lerman A
    Microvasc Res; 2020 Nov; 132():104040. PubMed ID: 32768463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Definition and epidemiology of vascular acrosyndromes].
    Carpentier PH
    Rev Prat; 1998 Oct; 48(15):1641-6. PubMed ID: 9814064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sympathectomy and microcirculation: physiopathologic reflections].
    Carpentier P; Magne JL; Guidicelli H; Franco A
    J Mal Vasc; 1985; 10 Suppl A():62-5. PubMed ID: 4031686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon.
    Anderson ME; Moore TL; Lunt M; Herrick AL
    Rheumatology (Oxford); 2007 Mar; 46(3):533-8. PubMed ID: 17018538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sparing of the thumb in Raynaud's phenomenon.
    Chikura B; Moore TL; Manning JB; Vail A; Herrick AL
    Rheumatology (Oxford); 2008 Feb; 47(2):219-21. PubMed ID: 18208825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone.
    Kahaleh B; Matucci-Cerinic M
    Arthritis Rheum; 1995 Jan; 38(1):1-4. PubMed ID: 7818557
    [No Abstract]   [Full Text] [Related]  

  • 30. Can people with Raynaud's phenomenon travel to high altitude?
    Luks AM; Grissom CK; Jean D; Swenson ER
    Wilderness Environ Med; 2009; 20(2):129-38. PubMed ID: 19594214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of vibration-induced white fingers--current opinion: a review.
    Liapina M; Tzvetkov D; Vodenitcharov E
    Cent Eur J Public Health; 2002 Jun; 10(1-2):16-20. PubMed ID: 12096677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury.
    Densmore JC; Signorino PR; Ou J; Hatoum OA; Rowe JJ; Shi Y; Kaul S; Jones DW; Sabina RE; Pritchard KA; Guice KS; Oldham KT
    Shock; 2006 Nov; 26(5):464-71. PubMed ID: 17047516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anorexia nervosa and Raynaud's phenomenon: a case report.
    Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
    Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
    Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G
    J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE; Gonzalez-Pares EN; Rivera C
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.